Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Cash from Investing Activities (2018 - 2026)

Alector's (ALEC) quarterly Cash from Investing Activities came in at $17.1 million in Q2 2026, down 69.28% year-over-year from $55.7 million in Q2 2025, and down 71.91% quarter-over-quarter from $60.9 million in Q1 2026.

Analysis

Alector (ALEC) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Cash from Investing Activities for 9 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 69.28% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $153.2 million, a 24.6% decrease from a year earlier, with the FY2025 full-year figure at $196.6 million, up 83.51% from the prior year.
  • Cash from Investing Activities was $17.1 million for Q2 2026 at Alector, down from $60.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $88.7 million in Q1 2023 and troughed at -$225.8 million in Q2 2022.
  • A 5-year average of $18.0 million and a median of $31.4 million in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities sank 499.04% in 2022 and soared 832.7% in 2023, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at $18.4 million in 2022, then retreated by 1.69% to $18.1 million in 2023, then soared by 129.11% to $41.4 million in 2024, then tumbled by 38.17% to $25.6 million in 2025, then slumped by 33.12% to $17.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at $17.1 million (Q2 2026), $60.9 million (Q1 2026), and $25.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -569.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.35 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -45.80 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -92.70 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 329.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -363.46 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -3.84 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 24.51 Mn
10 Alector 274.68 Mn 101.88 Mn - 17.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.12 Mn
Mar 31, 2026 60.95 Mn
Dec 31, 2025 25.60 Mn
Sep 30, 2025 49.54 Mn
Jun 30, 2025 55.72 Mn
Mar 31, 2025 65.74 Mn
Dec 31, 2024 41.40 Mn
Sep 30, 2024 40.35 Mn
Jun 30, 2024 37.15 Mn
Mar 31, 2024 -11.77 Mn
Dec 31, 2023 18.07 Mn
Sep 30, 2023 16.96 Mn
Jun 30, 2023 -21.82 Mn
Mar 31, 2023 88.70 Mn
Dec 31, 2022 18.38 Mn
Sep 30, 2022 60.53 Mn
Jun 30, 2022 -225.82 Mn
Mar 31, 2022 -12.11 Mn
Dec 31, 2021 -146.75 Mn
Sep 30, 2021 -69.05 Mn